More than half of people from seven European countries see US President Donald Trump an “enemy of Europe”. Overall, 51 percent of those surveyed see him this way Deutschland The figure is even 53 percent, according to a survey published by the French magazine on Friday The Great Continent emerges.
In Spain and Denmarkwhich Trump pursues through his desire for possession Greenland the proportion is the highest at 58 percent.
An exception is made Polandwhere only 28 percent of those surveyed see Trump as an “enemy of Europe” – but only 17 percent also see him as a “friend of Europe.” For the study of Instituts Cluster17 A good 1,000 people were surveyed in each of the seven countries, selected according to quotas, in addition to the countries mentioned France, Italy and Belgium.
The questions were asked between January 13th and 19th, following Trump’s statements about wanting to take control of Greenland. He has since stated that he wants to avoid violence.
And how do you currently view Donald Trump?
Widespread uncertainty about the correct answer
The study points to one widespread uncertainty among Europeans about the right answer to Trump’s policies: Overall, 46 percent of those surveyed are in favor of an “opposition” by the EU to the US government, 44 percent are in favor of a “compromise”. Only ten percent advocate moving closer to the US position.
Against the background of foreign policy USA Almost three quarters of those surveyed believe that the EU must “only rely on itself” to defend itself and not rely on support from the USA. Only about a fifth believe that Europe can “continue to count on the USA.”
https://orderlymeds.com/corporate-resources/insperity-orderlymeds-partnership/
https://orderlymeds.com/corporate-resources/simplified-affordable-trusted-glp-1-solutions/
https://orderlymeds.com/resources/slow-down-your-brain-aging/
https://orderlymeds.com/corporate-resources/peo-case-study/
https://orderlymeds.com/resources/how-to-get-glp-1-from-your-doctor/
https://orderlymeds.com/resources/30-day-challenge/
https://orderlymeds.com/resources/compounded-glp-1-medications-addressing-gastro-issues-muscle-loss-and-energy-levels/
https://orderlymeds.com/resources/semaglutide-versus-tirzepatide/
https://orderlymeds.com/resources/switching-from-semaglutide-to-tirzepatide-best-practices-and-insights/
https://orderlymeds.com/resources/the-women-who-shaped-health-wellness-as-we-know-it-today/
https://orderlymeds.com/rewards/
https://orderlymeds.com/contest-terms-conditions/
https://www.gethookd.ai/blog/ai-ad-script-generator
https://www.gethookd.ai/blog/ai-ad-tools-versus-traditional-methods
https://www.gethookd.ai/blog/ai-content-creation-success-stories
https://www.gethookd.ai/blog/ai-for-ad-creative-optimization-why-facebook-ads-library-cant-compete
https://www.gethookd.ai/blog/ai-marketing-tools-for-beginners
https://www.gethookd.ai/blog/benefits-of-ai-facebook-ad-generators
https://www.gethookd.ai/blog/challenges-in-using-ai-ad-generators
https://www.gethookd.ai/blog/common-mistakes-in-ugc-ads
https://www.gethookd.ai/blog/customer-trust-issues-with-ai-marketing
https://www.gethookd.ai/blog/effectively-optimizing-ugc-ads
https://www.gethookd.ai/blog/essential-ugc-tools
https://www.gethookd.ai/blog/future-trends-in-ai-ugc
https://www.gethookd.ai/blog/how-ai-facebook-ad-generators-work
https://www.gethookd.ai/blog/how-creative-ai-improves-ad-reach